Miller Anestesia

2248 / 2894

2248 Anestesia por subespecialidades en el adulto IV
33. Vaughn C, Mychaskiw G, Sewell P: Massive hemo-
rrhage during radiofrequency ablation of a pulmo-
nary neoplasm. Anesth Analg 94:1149–1151, 2002.
34. Menon DK, Peden CJ, Hall AS, et al: Magnetic reso-
nance for the anaesthetist. Part I: Physical principles,
applications,safetyaspects.Anaesthesia47:240–255,
1992.
35. Gadian DG: Nuclear magnetic resonance theory. In:
Nuclear Magnetic Resonance and Its Applications to
Living Systems. Oxford, Clarendon, 1982, pp 143.
36. Fundamentals of magnetic resonance imaging.
Council on Scientific Affairs. JAMA 258:3417-3423,
1987.
37. Berger A: Magnetic resonance imaging. BMJ 324:35,
2002.
38. Barth MM, Smith MP, Pedrosa I, et al: Body MRI
imaging at 3.0 T: Understanding the opportunities
and challenges. Radiographics 27:1445–1462, 2007.
39. Consensus Conference: Magnetic resonance
imaging. JAMA 14:2132–2138, 1988.
40. Kanal E, Shellock FG, Talagala L: Safety considera-
tions in MR imaging. Radiology 76:593–606, 1990.
41. Kanal E, Borgstede JP, Barkovich AJ, et al: American
College of Radiology White Paper on MRI Safety.
AJR Am J Roentgenol 178:1335–1347, 2002.
42. Dempsey MF, Condon B: Thermal injuries associa-
ted with MRI. Clin Radiol 56:457–465, 2001.
43. Achenbach S, Moshage W, Diem B, et al: Effects of
magnetic resonance imaging on cardiac pacemakers
and electrodes. Am Heart J 134:467–473, 1997.
44. Goldschlager N, Epstein A, Friedman P, et al: Envi-
ronmental and drug effects on patients with pace-
makers and implantable cardioverter/defibrillators:
A practical guide to patient treatment. Arch Intern
Med 161:649–655, 2001.
45. Wagle WA, Smith M: Tattoo-induced skin burn
duringMR imaging. AJRAmJ Roentgenol 174:1795,
2000.
46. TopeWD, imaging
and permanent cosmetics (tattoos): Survey of com-
plications and adverse events. JMagnReson Imaging
15:180–184, 2002.
47. Kremmer S, Schiefer U, Wilhelm H, Zrenner E:
Mobilization of intraocular foreign bodies by mag-
netic resonance tomography. Klin Monatsbl Augen-
heilkd 208:201–202, 1996.
48. Klucznik RP, Carrier DA, Pyka R, Haid RW: Place-
ment of a ferromagnetic intracerebral aneurysm
clip in a magnetic field with a fatal outcome. Radio-
logy 187:855–856, 1993.
49. Shellock FG, Tkach JA, Ruggieri PM, et al: Aneu-
rysm clips: Evaluation of magnetic field interactions
and translational attraction by use of “long-bore”
and “short-bore” 3.0-T MR imaging systems. AJNR
Am J Neuroradiol 24:463–471, 2003.
50. ECRI hazard report: Patient death illustrates the
importance of adhering to safety precautions in
magnetic resonance environments. Health Devices
30:311–314, 2001.
51. Chaljub G, Kramer LA, Johnson RF, et al: Projectile
cylinder accidents resulting from the presence of
ferromagnetic nitrous oxide or oxygen tanks in the
MR suite. AJR Am J Roentgenol 177:27–30, 2001.
52. Peden CJ, Menon DK, Hall AS, et al: Magnetic reso-
nance for the anaesthetist. Part II: Anaesthesia and
monitoring in MR units. Anaesthesia 47:508–517,
1992.
53. Holshouser BA, Hinshaw DB Jr, Shellock FG: Seda-
tion, anesthesia, and physiologic monitoring during
MR imaging: Evaluation of procedures and equip-
ment. J Magn Reson Imaging 3:553–558, 1993.
54. Zorab JSM: A general anaesthesia service for mag-
netic resonance imaging. Eur J Anaesthesiol 12:387–
395, 1995.
55. McBrien ME, Winer J, Smyth L: Anaesthesia for
magnetic resonance imaging: A survey of current
practice in the UK and Ireland. Anaesthesia 55:737–
743, 2000.
56. Gooden CK, Dilos B: Anesthesia for magnetic reso-
nance imaging. Int Anesthesiol Clin 41(2)29–37,
2003.
57. Strother CM: Interventional neuroradiology. AJNR
Am J Neuroradiol 21:19–24, 2000.
58. Young WL: Anesthesia for endovascular neurosur-
gery and interventional neuroradiology. Anesthesiol
Clin 25:391–412, 2007.
59. Johnston S, Claiborne MD, Higashida RT, et al:
Recommendations for the endovascular treatment
of intracranial aneurysms: A statement for health-
care professionals from the Committee on Cerebro-
vascular Imaging of the AmericanHeart Association
Council on Cardiovascular Radiology. Stroke
33:2536–2544, 2002.
60. Vinuela F, Duckwiler G, Mawad M: Guglielmi deta-
chable coil embolization of acute intracranial aneu-
rysm: Perioperative anatomical and clinical outcome
in 403 patients. J Neurosurg 86:475–482, 1997.
61. Higashida RT, Halbach VV, Dowd CF, et al: Intracra-
nial aneurysms: Interventional neurovascular
treatment with detachable balloons—results in 215
cases. Radiology 178:663–670, 1991.
62. Deveikis JP: Endovascular therapy of intracranial
arteriovenous malformations. Materials and techni-
ques. Neuroimaging Clin N Am 8:401–424, 1998.
63. Vinuela F, Dion JE, Duckwiler G, et al: Combined
endovascular embolization and surgery in the
management of cerebral arteriovenous malforma-
tions: Experience with 101 cases. J Neurosurg
75:856–864, 1991.
64. Chang SD, Marcellus ML, Marks MP, et al: Multimo-
dality treatment of giant intracranial arteriovenous
malformations. Neurosurgery 53:1–11, 2003.
65. Osborn IP: Anesthetic considerations for interven-
tional neuroradiology. Int Anesthesiol Clin 41(2)69–
77, 2003.
66. Pelz DM: Advances in interventional neuroradio-
logy. Stroke 34:357–358, 2003.
67. Gress DR, Smith WS, Dowd CF, et al: Angioplasty
for intracranial symptomatic vertebrobasilar ische-
mia. Neurosurgery 51:23–29, 2002.
68. Lylyk P, Cohen JE, Cerratto R, et al: Angioplasty and
stent placement in intracranial atherosclerotic ste-
noses and dissections. AJNR Am J Neuroradiol
23:430–436, 2002.
69. The National Institute of Neurologic Disorders and
Stroke rt-PA Stroke Study Group: Tissue plasmino-
gen activator for acute ischemic stroke. N Engl J
Med 333:1581–1587, 1995.
70. Thomassen L, Bakke SJ. Endovascular reperfusion
therapy in acute ischaemic stroke. Acta Neurol
Scand 115(S187):22–29, 2007.
71. Vahedi K, Bousser MG: Thrombolysis in stroke.
Curr Opin Hematol 9:443–447, 2002.
72. Wada J, Rasmussen T: Intracarotid injection of
sodium Amytal for the lateralization of cerebral
speech dominance. J Neurosurg 17:266–282, 1960.
73. Rauch RA, Viñuela F, Dion J, et al: Preembolization
functional evaluation in brain arteriovenous mal-
formations: The ability of superselective Amytal test
to predict neurologic dysfunction before emboliza-
tion. AJNR Am J Neuroradiol 13:309–314, 1992.
74. Deveikis JP: Sequential injections of amobarbital
sodium and lidocaine for provocative neurologic
testing in the external carotid circulation. AJNR Am
J Neuroradiol 17:1143–1147, 1996.
75. Judkins MP: Selective coronary arteriography. Part
1. A percutaneous transfemoral technic. Radiology
89:815–824, 1967.
76. Scanlon PJ, Faxon DP, Audet AM, et al: ACC/AHA
guidelines for coronary angiography: Executive
summary and recommendations. A report of the
American College of Cardiology/American Heart
Association Task Force on Practice Guidelines
(Committee on Coronary Angiography) developed
in collaboration with the Society for Cardiac Angio-
graphy and Interventions. Circulation 99:2345–
2357, 1999.
77. Kimmel SE, Berlin JA, Hennessy S, et al: Risk of
major complications from coronary angioplasty
performed immediately after diagnostic coronary
angiography: Results from the Registry of the
Society for Cardiac Angiography and Interventions.
J Am Coll Cardiol 30:193–200, 1997.
78. LaskeyW, Boyle J, Johnson LW: Multivariable model
for the prediction of significant complication during
diagnostic cardiac catheterization. The Registry
Committee of the Society for Cardiac Angiography
and Interventions. Cathet Cardiovasc Diagn
30:185–190, 1993.
79. Rihal CS, Holmes DR: Transradial cardiac cathete-
rization: Is femoral access obsolete? Am Heart
J 138:392–393, 1999.
80. Cooper CJ, El-Shiekh RA, Cohen DJ, et al: Effect of
transradial access on quality of life and cost of
cardiac catheterization: A randomized comparison.
Am Heart J 138:430–436, 1999.
81. Deutsch E: The emerging role of low-molecular
weight heparin and antiplatelet therapies in the
cardiac catheterization laboratory. Am Heart
J 138:S577–S585, 1999.
82. The EPIC Investigators: Use of a monoclonal anti-
body directed against the platelet glycoprotein IIb/
IIIa receptor in high-risk coronary angioplasty. N
Engl J Med 330:956–961, 1994.
83. Topol EJ, Califf RM, Weisman H, et al: Randomised
trial of coronary intervention with antibody against
platelet IIb/IIIa integrin for reduction of clinical
restenosis: Results at six months. Lancet 343:881–
890, 1994.
84. The EPILOG Investigators: Platelet glycoprotein
IIb/IIIa receptor blockade and low-dose heparin
during percutaneous coronary revascularization. N
Engl J Med 336:1689–1696, 1997.
85. The CAPTURE Investigators: Randomized placebo-
controlled trial of abciximab before and during
coronary intervention in refractory unstable angina:
The CAPTURE study. Lancet 349:1429–1435, 1997.
86. Ferguson JJ, Kereiakes DJ, Adgey AA, et al: Safe use
of platelet GP IIb/IIIa inhibitors. Eur Heart J
19(Suppl D)D40–D51, 1998.
87. McIvor ME, Undemir C, Lawson J, Reddinger J: Cli-
nical effects and utility of intracoronary diltiazem.
Cathet Cardiovasc Diagn 35:287–291, 1995.
88. Barnes RD, Abel MD, Rihal CS: Anesthesia and
interventional cardiology. In Thys DM, Hillel Z,
Schwartz AJ (eds): Cardiothoracic Anesthesiology.
New York, McGraw-Hill, 2001.
89. Vlietstra RE, Holmes DR Jr, Smith HC, et al: Percu-
taneous transluminal coronary angioplasty: Initial
Mayo Clinic experience. Mayo Clin Proc 56:287–
293, 1981.
90. Holmes DR Jr, Garratt KN, Isner JM, et al: Effect of
subintimal resection on initial outcome and reste-
nosis for native coronary lesions and saphenous vein
graft disease treated by directional coronary athe-
rectomy: A report from the CAVEAT I and II inves-
tigators. Coronary Angioplasty Versus Excisional
Atherectomy Trial. J Am Coll Cardiol 28:645–651,
1996.
91. Neuhaus KL, Zeymer U: Prevention and manage-
ment of thrombotic complications during coronary
interventions. Combination therapy with anti-
thrombins, antiplatelets, and/or thrombolytics: Risks
and benefits. Eur Heart J 16(Suppl L)63–67, 1995.
92. Adgey AA: Bleeding complications with new anti-
thrombotics used in ischaemic heart disease. Hae-
mostasis 26:237–246, 1996.
93. Heikkinen L, Virtanen K, Heikkila J, et al: Surgical
treatment of acute myocardial ischaemia related to
coronary angioplasty with special reference to use
of perfusion balloon catheter and long-term
outcome. J Cardiovasc Surg (Torino) 38:101–106,
1997.
94. Berger PB, Stensrud PE, Daly RC, et al: Time to
reperfusion and other procedural characteristics of
emergency coronary artery bypass surgery after
unsuccessful coronary angioplasty. Am J Cardiol
76:565–569, 1995.
95. Schwartz RS, Topol EJ, Serruys PW, et al: Artery size,
neointima, and remodeling: Time for some stan-
dards. J Am Coll Cardiol 32:2087–2094, 1998.
96. Umans VA, Melkert R, Foley DP, Serruys PW: Clini-
cal and angiographic comparison of matched
patients with successful directional coronary athe-
rectomy or stent implantation for primary coronary
artery lesions. J Am Coll Cardiol 28:637–644, 1996.
97. Dixon SR, Grines CL, O’Neill WW: The year in
interventional cardiology. J Am Coll Cardiol
50:270–285, 2007.